Annual CAPEX
$17.05 M
+$4.49 M+35.80%
December 31, 2024
Summary
- As of March 13, 2025, RXRX annual capital expenditures is $17.05 million, with the most recent change of +$4.49 million (+35.80%) on December 31, 2024.
- During the last 3 years, RXRX annual CAPEX has fallen by -$22.75 million (-57.17%).
- RXRX annual CAPEX is now -57.17% below its all-time high of $39.80 million, reached on December 31, 2021.
Performance
RXRX CAPEX Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly CAPEX
$1.65 M
-$2.91 M-63.88%
December 31, 2024
Summary
- As of March 13, 2025, RXRX quarterly capital expenditures is $1.65 million, with the most recent change of -$2.91 million (-63.88%) on December 31, 2024.
- Over the past year, RXRX quarterly CAPEX has dropped by -$2.91 million (-63.88%).
- RXRX quarterly CAPEX is now -91.51% below its all-time high of $19.42 million, reached on March 31, 2021.
Performance
RXRX Quarterly CAPEX Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM CAPEX
$17.05 M
-$769.00 K-4.32%
December 31, 2024
Summary
- As of March 13, 2025, RXRX TTM capital expenditures is $17.05 million, with the most recent change of -$769.00 thousand (-4.32%) on December 31, 2024.
- Over the past year, RXRX TTM CAPEX has dropped by -$769.00 thousand (-4.32%).
- RXRX TTM CAPEX is now -57.31% below its all-time high of $39.92 million, reached on September 30, 2021.
Performance
RXRX TTM CAPEX Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
RXRX CAPEX Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +35.8% | -63.9% | -4.3% |
| 3 y3 years | -57.2% | -63.9% | -4.3% |
| 5 y5 years | +335.9% | -63.9% | -4.3% |
RXRX CAPEX Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -57.2% | +35.8% | -90.0% | +99.3% | -57.2% | +35.8% |
| 5 y | 5-year | -57.2% | +335.9% | -91.5% | +99.5% | -57.3% | +1963.6% |
| alltime | all time | -57.2% | +335.9% | -91.5% | +99.5% | -57.3% | +1963.6% |
Recursion Pharmaceuticals CAPEX History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2024 | $17.05 M(+35.8%) | $1.65 M(-63.9%) | $17.05 M(-4.3%) |
| Sep 2024 | - | $4.56 M(+9.1%) | $17.81 M(+26.5%) |
| Jun 2024 | - | $4.18 M(-37.1%) | $14.08 M(+1.5%) |
| Mar 2024 | - | $6.65 M(+175.3%) | $13.87 M(+10.5%) |
| Dec 2023 | $12.55 M(-66.4%) | $2.42 M(+192.3%) | $12.55 M(-30.7%) |
| Sep 2023 | - | $827.00 K(-79.2%) | $18.11 M(-29.9%) |
| Jun 2023 | - | $3.97 M(-25.7%) | $25.85 M(-32.6%) |
| Mar 2023 | - | $5.34 M(-33.1%) | $38.36 M(+2.7%) |
| Dec 2022 | $37.36 M | $7.98 M(-6.8%) | $37.36 M(+10.4%) |
| Sep 2022 | - | $8.56 M(-48.0%) | $33.84 M(-3.3%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2022 | - | $16.48 M(+279.4%) | $34.99 M(+41.5%) |
| Mar 2022 | - | $4.34 M(-2.7%) | $24.72 M(-37.9%) |
| Dec 2021 | $39.80 M(+490.9%) | $4.46 M(-54.0%) | $39.80 M(-0.3%) |
| Sep 2021 | - | $9.71 M(+56.2%) | $39.92 M(+28.6%) |
| Jun 2021 | - | $6.21 M(-68.0%) | $31.05 M(+25.0%) |
| Mar 2021 | - | $19.42 M(+322.9%) | $24.83 M(+358.4%) |
| Dec 2020 | $6.74 M(+72.3%) | - | - |
| Dec 2020 | - | $4.59 M(+455.8%) | $5.42 M(+555.8%) |
| Sep 2020 | - | $826.00 K | $826.00 K |
| Dec 2019 | $3.91 M | - | - |
FAQ
- What is Recursion Pharmaceuticals annual capital expenditures?
- What is the all time high annual CAPEX for Recursion Pharmaceuticals?
- What is Recursion Pharmaceuticals annual CAPEX year-on-year change?
- What is Recursion Pharmaceuticals quarterly capital expenditures?
- What is the all time high quarterly CAPEX for Recursion Pharmaceuticals?
- What is Recursion Pharmaceuticals quarterly CAPEX year-on-year change?
- What is Recursion Pharmaceuticals TTM capital expenditures?
- What is the all time high TTM CAPEX for Recursion Pharmaceuticals?
- What is Recursion Pharmaceuticals TTM CAPEX year-on-year change?
What is Recursion Pharmaceuticals annual capital expenditures?
The current annual CAPEX of RXRX is $17.05 M
What is the all time high annual CAPEX for Recursion Pharmaceuticals?
Recursion Pharmaceuticals all-time high annual capital expenditures is $39.80 M
What is Recursion Pharmaceuticals annual CAPEX year-on-year change?
Over the past year, RXRX annual capital expenditures has changed by +$4.49 M (+35.80%)
What is Recursion Pharmaceuticals quarterly capital expenditures?
The current quarterly CAPEX of RXRX is $1.65 M
What is the all time high quarterly CAPEX for Recursion Pharmaceuticals?
Recursion Pharmaceuticals all-time high quarterly capital expenditures is $19.42 M
What is Recursion Pharmaceuticals quarterly CAPEX year-on-year change?
Over the past year, RXRX quarterly capital expenditures has changed by -$2.91 M (-63.88%)
What is Recursion Pharmaceuticals TTM capital expenditures?
The current TTM CAPEX of RXRX is $17.05 M
What is the all time high TTM CAPEX for Recursion Pharmaceuticals?
Recursion Pharmaceuticals all-time high TTM capital expenditures is $39.92 M
What is Recursion Pharmaceuticals TTM CAPEX year-on-year change?
Over the past year, RXRX TTM capital expenditures has changed by -$769.00 K (-4.32%)